Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

PJ Martin, BJ Nelson, FR Appelbaum, C Anasetti, HJ Deeg, JA Hansen, GB McDonald, RA Nash, KM Sullivan, RP Witherspoon, PJ Scannon, N Friedmann, R Storb

Blood (1996) 88 (3): 824–830.

https://doi.org/10.1182/blood.V88.3.824.824

Published: 1996

Journal Articles

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Blood (1996) 87 (1): 51–58.

https://doi.org/10.1182/blood.V87.1.51.51

Published: 1996

Journal Articles

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients

HJ Deeg, G Socie, G Schoch, M Henry-Amar, RP Witherspoon, A Devergie, KM Sullivan, E Gluckman, R Storb

Blood (1996) 87 (1): 386–392.

https://doi.org/10.1182/blood.V87.1.386.386

Published: 1996

Journal Articles

Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter; comment]

RP Witherspoon, R Storb, M Pepe, G Longton, KM Sullivan

Blood (1992) 79 (1): 289–291.

https://doi.org/10.1182/blood.V79.1.289.289

Published: 1992

Journal Articles

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

KM Sullivan, PL Weiden, R Storb, RP Witherspoon, A Fefer, L Fisher, CD Buckner, C Anasetti, FR Appelbaum, C Badger

Blood (1989) 73 (6): 1720–1728.

https://doi.org/10.1182/blood.V73.6.1720.1720

Published: 1989

Journal Articles

HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration

PJ Martin, RA Clift, LD Fisher, CD Buckner, JA Hansen, FR Appelbaum, KC Doney, KM Sullivan, RP Witherspoon, R Storb

Blood (1988) 72 (6): 1978–1984.

https://doi.org/10.1182/blood.V72.6.1978.1978

Published: 1988

Journal Articles

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation

KM Sullivan, RP Witherspoon, R Storb, P Weiden, N Flournoy, S Dahlberg, HJ Deeg, JE Sanders, KC Doney, FR Appelbaum

Blood (1988) 72 (2): 546–554.

https://doi.org/10.1182/blood.V72.2.546.546

Published: 1988

Journal Articles

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

KM Sullivan, RP Witherspoon, R Storb, HJ Deeg, S Dahlberg, JE Sanders, FR Appelbaum, KC Doney, P Weiden, C Anasetti

Blood (1988) 72 (2): 555–561.

https://doi.org/10.1182/blood.V72.2.555.555

Published: 1988

Journal Articles

Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors

K Matsue, LG Lum, RP Witherspoon, R Storb

Blood (1987) 69 (1): 308–315.

https://doi.org/10.1182/blood.V69.1.308.308

Published: 1987

Journal Articles

Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors

HJ Deeg, S Self, R Storb, K Doney, FR Appelbaum, RP Witherspoon, KM Sullivan, K Sheehan, J Sanders, E Mickelson

Blood (1986) 68 (6): 1363–1368.

https://doi.org/10.1182/blood.V68.6.1363.1363

Published: 1986

Journal Articles

Growth and development following marrow transplantation for leukemia

JE Sanders, S Pritchard, P Mahoney, D Amos, CD Buckner, RP Witherspoon, HJ Deeg, KC Doney, KM Sullivan, FR Appelbaum

Blood (1986) 68 (5): 1129–1135.

https://doi.org/10.1182/blood.V68.5.1129.1129

Published: 1986

Journal Articles

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

PJ Martin, JA Hansen, CD Buckner, JE Sanders, HJ Deeg, P Stewart, FR Appelbaum, R Clift, A Fefer, RP Witherspoon

Blood (1985) 66 (3): 664–672.

https://doi.org/10.1182/blood.V66.3.664.664

Published: 1985

Journal Articles

Donor cell leukemia developing six years after marrow grafting for acute leukemia

RP Witherspoon, W Schubach, P Neiman, P Martin, ED Thomas

Blood (1985) 65 (5): 1172–1174.

https://doi.org/10.1182/blood.V65.5.1172.1172

Published: 1985

Journal Articles

Marrow harvesting from normal donors

CD Buckner, RA Clift, JE Sanders, P Stewart, WI Bensinger, KC Doney, KM Sullivan, RP Witherspoon, HJ Deeg, FR Appelbaum

Blood (1984) 64 (3): 630–634.

https://doi.org/10.1182/blood.V64.3.630.630

Published: 1984

Journal Articles

Fanconi's anemia treated by allogeneic marrow transplantation

HJ Deeg, R Storb, ED Thomas, F Appelbaum, CD Buckner, RA Clift, K Doney, L Johnson, JE Sanders, P Stewart, KM Sullivan, RP Witherspoon

Blood (1983) 61 (5): 954–959.

https://doi.org/10.1182/blood.V61.5.954.954

Published: 1983

Journal Articles

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

R Storb, RL Prentice, M Banaji, RP Witherspoon, KM Sullivan, P Stewart, JE Sanders, M Mason, K Doney, J Deeg, RA Clift, CD Buckner, FR Appelbaum, ED Thomas

Blood (1983) 61 (4): 672–675.

https://doi.org/10.1182/blood.V61.4.672.672

Published: 1983

Journal Articles

Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease

K Atkinson, V Farewell, R Storb, MS Tsoi, KM Sullivan, RP Witherspoon, A Fefer, R Clift, B Goodell, ED Thomas

Blood (1982) 60 (3): 714–720.

https://doi.org/10.1182/blood.V60.3.714.714

Published: 1982

Journal Articles

In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3- 4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy

RP Witherspoon, LG Lum, R Storb, ED Thomas

Blood (1982) 59 (4): 844–850.

https://doi.org/10.1182/blood.V59.4.844.844

Published: 1982

Journal Articles

Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients

R Storb, KC Doney, ED Thomas, F Appelbaum, CD Buckner, RA Clift, HJ Deeg, BW Goodell, R Hackman, JA Hansen, J Sanders, K Sullivan, PL Weiden, RP Witherspoon

Blood (1982) 59 (2): 236–246.

https://doi.org/10.1182/blood.V59.2.236.236

Published: 1982

Journal Articles

In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease

LG Lum, MC Seigneuret, RF Storb, RP Witherspoon, ED Thomas

Blood (1981) 58 (3): 431–439.

https://doi.org/10.1182/blood.V58.3.431.431

Published: 1981

NARROW

Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients

Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [letter; comment]

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia [published erratum appears in Blood 1989 Aug 15;74(3):1180]

HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation

Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease

Proliferative and differentiative responses of B cells from human marrow graft recipients to T cell-derived factors

Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors

Growth and development following marrow transplantation for leukemia

Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

Donor cell leukemia developing six years after marrow grafting for acute leukemia

Marrow harvesting from normal donors

Fanconi's anemia treated by allogeneic marrow transplantation

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease

In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3- 4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy

Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients

In vitro regulation of immunoglobulin synthesis after marrow transplantation. I. T-cell and B-cell deficiencies in patients with and without chronic graft-versus-host disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only